{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:24:03Z","timestamp":1774621443396,"version":"3.50.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic beryllium disease (CBD) provides a model system in which to evaluate the antigen-stimulated, cell-mediated, immune response that leads to granulomatous lung disease. We hypothesized that beryllium salts would stimulate bronchoalveolar lavage (BAL) cell release of tumor necrosis factor- \u03b1 (TNF- \u03b1 ) and interleukin-6 (IL-6), and their soluble receptors, soluble TNF receptor I (sTNF RI), sTNF RII, and sIL-6R and that chronic exposure to antigen would increase production of soluble receptors in the serum and BAL fluid (BALF) of beryllium-sensitized and CBD patients. We have demonstrated (1) similar constitutive TNF- \u03b1, IL-6, and soluble receptor production by control subjects and CBD patients, (2) a BeSO4-stimulated increase in TNF- \u03b1 and IL-6 production by CBD-derived BAL cells, and (3) a BeSO4-induced decrease in sTNF RII production by BAL cells from control subjects. We measured increased serum sTNF RI and serum and BALF sIL-6R in beryllium-sensitized subjects and increased sTNF RI and RII in serum and sIL-6R and sTNF RII and BALF in CBD patients. These changes correlated with pulmonary lymphocytosis and clinical measures of disease severity, indicating that soluble receptors may reflect disease status.<\/jats:p>","DOI":"10.1164\/ajrccm.156.6.9610040","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T13:26:37Z","timestamp":1365081997000},"page":"1884-1891","source":"Crossref","is-referenced-by-count":53,"title":["Beryllium-stimulated Release of Tumor Necrosis Factor- \u03b1, Interleukin-6, and Their Soluble Receptors in Chronic Beryllium Disease"],"prefix":"10.1093","volume":"156","author":[{"given":"SALLY S.","family":"TINKLE","sequence":"first","affiliation":[{"name":"National Jewish Medical and Research Center, Division of Environmental and Occupational Health Sciences, National Jewish Center for Immunology and Respiratory Medicine; and Division of Pulmonary Sciences and Critical Care Medicine, Departments of Medicine and Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEE S.","family":"NEWMAN","sequence":"additional","affiliation":[{"name":"National Jewish Medical and Research Center, Division of Environmental and Occupational Health Sciences, National Jewish Center for Immunology and Respiratory Medicine; and Division of Pulmonary Sciences and Critical Care Medicine, Departments of Medicine and Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1997,12,1]]},"reference":[{"key":"2026032709262968800_B1","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.4049\/jimmunol.154.11.5969","article-title":"Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation.","volume":"154","author":"Chensue","year":"1995","journal-title":"J. Immunol"},{"key":"2026032709262968800_B2","first-page":"7","article-title":"Beryllium disease and sarcoidosis: clinical and laboratory links.","volume":"12","author":"Newman","year":"1995","journal-title":"Sarcoidosis"},{"key":"2026032709262968800_B3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1165\/ajrcmb\/1.6.439","article-title":"Cellular and molecular aspects of granulomatous inflammation.","volume":"1","author":"Kunkel","year":"1989","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"2026032709262968800_B4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.1994.tb39791.x","article-title":"Cytokines and airway inflammation.","volume":"725","author":"Howarth","year":"1994","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"2026032709262968800_B5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1165\/ajrcmb.10.5.8179912","article-title":"Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for TNF-\u03b1 and IL-6 but not IL-1.","volume":"10","author":"Bost","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"2026032709262968800_B6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/infdis\/172.1.301","article-title":"Assessment of a possible imbalance between tumor necrosis factor (TNF) and soluble TNF receptor forms in tuberculous infection of the central nervous system.","volume":"172","author":"Rydberg","year":"1995","journal-title":"J. Infect. Dis"},{"key":"2026032709262968800_B7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-108-5-687","article-title":"Proliferative response of bronchoalveolar lymphocytes to beryllium: a test for chronic beryllium disease.","volume":"108","author":"Rossman","year":"1988","journal-title":"Ann. Intern. Med"},{"key":"2026032709262968800_B8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0091-6749(91)90300-D","article-title":"Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.","volume":"88","author":"Mroz","year":"1991","journal-title":"J. Allergy Clin. Immunol"},{"key":"2026032709262968800_B9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-3083.1995.tb03639.x","article-title":"TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action.","volume":"42","author":"Brennan","year":"1995","journal-title":"Scand. J. Immunol"},{"key":"2026032709262968800_B10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/eji.1830230408","article-title":"Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy.","volume":"23","author":"Gaillard","year":"1993","journal-title":"Eur. J. Immunol"},{"key":"2026032709262968800_B11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/infdis\/172.2.433","article-title":"Correlation between proinflammatory cytokines and anti-inflammatory mediators and the severity of disease in meningococcal infections.","volume":"172","author":"van Deuren","year":"1995","journal-title":"J. Infect. Dis"},{"key":"2026032709262968800_B12"},{"key":"2026032709262968800_B13"},{"key":"2026032709262968800_B14","first-page":"185","article-title":"Standardized single breath normal values for carbon monoxide diffusing capacity.","volume":"123","author":"Crapo","year":"1981","journal-title":"Am. Rev. Respir. Dis"},{"key":"2026032709262968800_B15"},{"key":"2026032709262968800_B16"},{"key":"2026032709262968800_B17"},{"key":"2026032709262968800_B18","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.4049\/jimmunol.151.10.5631","article-title":"Mechanisms of release of soluble forms of tumor necrosis factor\/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-I cells in vitro.","volume":"151","author":"Hwang","year":"1993","journal-title":"J. Immunol"},{"key":"2026032709262968800_B19","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.4049\/jimmunol.152.8.4036","article-title":"Slow release of soluble TNF receptors by monocytes in vitro.","volume":"152","author":"Leeuwenberg","year":"1994","journal-title":"J. Immunol"},{"key":"2026032709262968800_B20","first-page":"21","article-title":"Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF.","volume":"84","author":"Cope","year":"1995","journal-title":"Immunology"},{"key":"2026032709262968800_B21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1042\/bj0980094","article-title":"The inhibition of enzymes by beryllium.","volume":"98","author":"Thomas","year":"1966","journal-title":"Biochem. J"},{"key":"2026032709262968800_B22"},{"key":"2026032709262968800_B23","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1073\/pnas.73.7.2331","article-title":"Metal-induced infidelity during DNA synthesis.","volume":"73","author":"Sirover","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"2026032709262968800_B24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0009-2797(79)90020-6","article-title":"Binding of beryllium to nuclear acidic proteins.","volume":"26","author":"Parker","year":"1979","journal-title":"Chem-Biol. Interact"},{"key":"2026032709262968800_B25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4049\/jimmunol.158.1.518","article-title":"Beryllium induces IL-2 and IFN-\u03b3 in berylliosis.","volume":"158","author":"Tinkle","year":"1997","journal-title":"J. Immunol"},{"key":"2026032709262968800_B26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1432-1033.1990.tb15548.x","article-title":"Studies on the structure and regulation of the human hepatic interleukin-6 receptor.","volume":"190","author":"Rose-John","year":"1990","journal-title":"Eur. J. Biochem"},{"key":"2026032709262968800_B27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1432-1033.1993.tb18138.x","article-title":"Recombinant soluble human interleukin-6 receptor: expression in Escherichia coli, renaturation, and purification.","volume":"216","author":"Stoyan","year":"1993","journal-title":"Eur. J. Biochem"},{"key":"2026032709262968800_B28","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.4049\/jimmunol.150.10.4346","article-title":"Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1.","volume":"150","author":"Winzen","year":"1993","journal-title":"J. Immunol"},{"key":"2026032709262968800_B29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1084\/jem.175.2.323","article-title":"Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.","volume":"175","author":"Aderka","year":"1992","journal-title":"J. Exp. Med"},{"key":"2026032709262968800_B30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1749-6632.1994.tb39815.x","article-title":"Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes.","volume":"725","author":"Nicod","year":"1994","journal-title":"Ann. N.Y. Acad. Sci"},{"key":"2026032709262968800_B31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1165\/ajrcmb.14.3.8845179","article-title":"Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon-\u03b3.","volume":"14","author":"Galve-de-Rochemonteix","year":"1996","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"2026032709262968800_B32","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/infdis\/167.6.1344","article-title":"Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans.","volume":"167","author":"Shapiro","year":"1993","journal-title":"J. Infect. Dis"},{"key":"2026032709262968800_B33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1164\/ajrccm.150.1.8025739","article-title":"Compartmentalized immune response reflects clinical severity of beryllium disease.","volume":"150","author":"Newman","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"2026032709262968800_B34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/171.2.469","article-title":"Circulating interleukin-6 receptor in patients with sepsis syndrome.","volume":"171","author":"Frieling","year":"1995","journal-title":"J. Infect. Dis"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/156\/6\/1884\/67451014\/ajrccm_156_6_1884.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/156\/6\/1884\/67451014\/ajrccm_156_6_1884.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:26:37Z","timestamp":1774617997000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/156\/6\/1884\/8531165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12,1]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1997,12,1]]},"published-print":{"date-parts":[[1997,12,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.156.6.9610040","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1997,12]]},"published":{"date-parts":[[1997,12,1]]}}}